The health system and Thermo Fisher will create a company called Precure to generate population-scale molecular data to inform development of diagnostics, therapies and other healthcare products.
Mayo Clinic, Thermo Fisher partner to create biomedical database Read More »
Citing “chronic underperformance,” Jana Partners is calling for new leadership and for the company to evaluate the sale of its fertility and medical device assets.
Activist investor urges Cooper Companies to replace CEO, sell some assets Read More »
Novo has “gone shopping” to fill pipeline gaps, with a focus on obesity and diabetes, plus an expansion in blood and endocrine disorders, liver diseases and cardiovascular conditions.
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting Read More »
The company will generate population-scale molecular data to inform development of diagnostics, therapies and other healthcare products.
Mayo Clinic, Thermo Fisher partner to create Precure Read More »
Aside from its manufacturing and distribution footprint, ITM Isotope Technologies Munich will give Telix Pharmaceuticals the late-stage ITM-11, being developed for gastroenteropancreatic neuroendocrine tumors. The asset was rejected by the FDA last month for manufacturing concerns.
Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A Read More »
Investors and analysts have been hounding Novo to beef up its pipeline and advance new molecules as a majority of the company’s sales stem from its semaglutide franchise.
Novo buys three early-stage obesity assets from Kallyope as investor pressure mounts Read More »
Healthcare organizations are rich in clinical data, but much of it is fragmented and unstructured. How can AI help transform it into structured, research-ready variables?
How AI is tackling one of the biggest bottlenecks in clinical research and beyond Read More »
The true cost of payment operations sits in four budgets. What happens when you add them up?
Uncovering the hidden costs of healthcare payments Read More »
Disconnected care can be a major – and often overlooked – driver of unnecessary healthcare costs.
La teoría de la relatividad general de Albert Einstein nos enseñó que nada, ni siquiera la luz, puede escapar del horizonte de sucesos de un agujero negro. Sin embargo, las ecuaciones matemáticas que describen estos monstruos cósmicos esconden un reverso especular: …
